Product Code: 978-1-68038-139-9
Medical Imaging Market Growth & Trends
The global medical imaging market size is expected to reach USD 47.4 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.8% from 2023 to 2030. Increasing demand for advanced diagnostic systems in developing countries and growing trends of market player collaborations are some of the key factors driving the market.
Developing countries have shown a surge in the volume of imaging procedures in the past few years. The low density of installed imaging systems in these regions is expected to provide significant growth potential during the forecast period. Favorable government policies and booming medical tourism in these countries are expected to attract global market players in the untapped market. The integration of multiple imaging modalities is expected to play an important role in market growth. These systems have accurate diagnostic capabilities and are available at affordable prices. The integration of imaging modalities with surgical suites is anticipated to open a new avenue for the market at the global level.
The development of portable diagnostic tools is important to expand the applications of imaging devices in ambulatory care, clinics, and emergency care departments. Handheld ultrasound devices provide quick and safer images that are critical in emergency care. Ongoing trials and studies to explore the potential of MRI technology for the early detection of neurological conditions are showing positive results. The development of new radiofrequency coils is anticipated to expand these applications during the forecast period.
Medical Imaging Market Report Highlights
- The ultrasound product segment captured the largest market share of 31.6% in 2022. The segment is expected to dominate the market throughout the forecast period
- The Computed Tomography (CT) segment is expected to grow at the fastest CAGR during the forecast period
- This is due to the rapid technological advancements, such as the development of hybrid imaging modalities and the integration of AI
- Based on end-uses, the hospital segment captured the largest share of 47.1% in 2022 due to the blooming healthcare service industry in developing countries
- North America led the global market and accounted for the largest revenue share of 32.9% in 2022
- The region's growth is credited to the presence of a large number of industry players and the high frequency of new product launches
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. End use
- 1.1.3. Region
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Medical Imaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Growing prevalence of cancer and cardiac diseases
- 3.3.1.2. Favorable government initiatives
- 3.3.1.3. Trends of preventive healthcare and disease screening programs
- 3.3.1.4. Strategic collaborations
- 3.3.1.5. Technological advancements
- 3.3.2. Market restraint analysis
- 3.3.2.1. High cost
- 3.3.2.2. Increasing use of refurbished products
- 3.3.2.3. Lack of regulations in developing countries
- 3.3.2.4. Lack of trained radiologists
- 3.3.3. Industry challenges
- 3.3.3.1. Product recall
- 3.3.3.2. Safety concerns
- 3.4. Medical Imaging Market Analysis Tools
- 3.4.1. Industry analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.3. Major deals & strategic alliances analysis
- 3.4.4. Market entry strategies
Chapter 4. Medical Imaging Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. X-ray devices
- 4.1.2. Computed Tomography
- 4.1.3. MRI equipment
- 4.1.4. Ultrasound
- 4.1.5. Nuclear Imaging systems
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Medical Imaging Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
- 4.5.1. X-ray devices
- 4.5.1.1. X-ray devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.2. X-ray devices market estimates and forecasts, by modality Revenue, USD Million 2018 - 2030
- 4.5.1.2.1. Radiography
- 4.5.1.2.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.2.2. Fluoroscopy
- 4.5.1.2.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.1.2.3. Mammography
- 4.5.1.2.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.2. Ultrasound
- 4.5.2.1. Ultrasound market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.2.2. Ultrasound market estimates and forecasts, by portability Revenue, USD Million 2018 - 2030
- 4.5.2.2.1. Handheld
- 4.5.2.2.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.2.2.2. Cart/trolley based
- 4.5.2.2.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.3. Computed Tomography
- 4.5.3.1. Computed Tomography market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.3.2. Computed Tomography market estimates and forecasts, by technology, Revenue, 2018 - 2030 (USD Million)
- 4.5.3.2.1. High end slice
- 4.5.3.2.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.3.2.2. Mid end slice
- 4.5.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.3.2.3. Low end slice
- 4.5.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.3.2.4. Cone beam
- 4.5.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.4. Magnetic Resonance Imaging
- 4.5.4.1. MRI market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.4.2. MRI market estimates and forecasts, by architecture, Revenue, 2018 - 2030 (USD Million)
- 4.5.4.2.1. Closed
- 4.5.4.2.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.4.2.2. Open
- 4.5.4.2.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.5. Nuclear Imaging
- 4.5.5.1. Nuclear imaging market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.5.2. Nuclear imaging market estimates and forecasts, by product, Revenue, 2018 - 2030 (USD Million)
- 4.5.5.2.1. SPECT
- 4.5.5.2.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 4.5.5.2.2. PET
- 4.5.5.2.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 5. Medical Imaging Market: End-use Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Hospitals
- 5.1.2. Diagnostic imaging centers
- 5.1.3. Ambulatory imaging centers
- 5.1.4. Others
- 5.2. End-use Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Medical Imaging Market by End-use Outlook
- 5.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
- 5.5.1. Hospitals
- 5.5.1.1. Market estimates and forecasts, USD Million, 2018 to 2030
- 5.5.2. Diagnostic Imaging Centers
- 5.5.2.1. Market estimates and forecasts, USD Million, 2018 to 2030
- 5.5.3. Ambulatory Imaging Centers
- 5.5.3.1. Market estimates and forecasts, USD Million, 2018 to 2030
- 5.5.4. Others
- 5.5.4.1. Market estimates and forecasts, USD Million, 2018 to 2030
Chapter 6. Medical Imaging Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2022 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Regional Market Share and Leading Players, 2022
- 6.4.1. North America
- 6.4.2. Europe
- 6.4.3. Asia Pacific
- 6.4.4. Latin America
- 6.4.5. Middle East and Africa
- 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 6.5.1. North America
- 6.5.2. Europe
- 6.5.3. Asia Pacific
- 6.5.4. Latin America
- 6.5.5. Middle East and Africa
- 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2028
- 6.7. North America
- 6.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. U.S.
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Competitive Scenario
- 6.7.2.3. Regulatory framework
- 6.7.2.4. Reimbursement scenario
- 6.7.2.5. Market estimates and forecasts, 2018 - 2030
- 6.7.3. Canada
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Competitive Scenario
- 6.7.3.3. Regulatory framework
- 6.7.3.4. Reimbursement scenario
- 6.7.3.5. Market estimates and forecasts, 2018 - 2030
- 6.8. Europe
- 6.8.1. U.K.
- 6.8.1.1. Key country dynamics
- 6.8.1.2. Competitive Scenario
- 6.8.1.3. Regulatory framework
- 6.8.1.4. Reimbursement scenario
- 6.8.1.5. Market estimates and forecasts, 2018 - 2030
- 6.8.2. Germany
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Competitive Scenario
- 6.8.2.3. Regulatory framework
- 6.8.2.4. Reimbursement scenario
- 6.8.2.5. Market estimates and forecasts, 2018 - 2030
- 6.8.3. France
- 6.8.3.1. Key country dynamics
- 6.8.3.2. Competitive Scenario
- 6.8.3.3. Regulatory framework
- 6.8.3.4. Reimbursement scenario
- 6.8.3.5. Market estimates and forecasts, 2018 - 2030
- 6.8.4. Italy
- 6.8.4.1. Key country dynamics
- 6.8.4.2. Competitive Scenario
- 6.8.4.3. Regulatory framework
- 6.8.4.4. Reimbursement scenario
- 6.8.4.5. Market estimates and forecasts, 2018 - 2030
- 6.8.5. Spain
- 6.8.5.1. Key country dynamics
- 6.8.5.2. Competitive Scenario
- 6.8.5.3. Regulatory framework
- 6.8.5.4. Reimbursement scenario
- 6.8.5.5. Market estimates and forecasts, 2018 - 2030
- 6.8.6. Denmark
- 6.8.6.1. Key country dynamics
- 6.8.6.2. Competitive Scenario
- 6.8.6.3. Regulatory framework
- 6.8.6.4. Reimbursement scenario
- 6.8.6.5. Market estimates and forecasts, 2018 - 2030
- 6.8.7. Sweden
- 6.8.7.1. Key country dynamics
- 6.8.7.2. Competitive Scenario
- 6.8.7.3. Regulatory framework
- 6.8.7.4. Reimbursement scenario
- 6.8.7.5. Market estimates and forecasts, 2018 - 2030
- 6.8.8. Norway
- 6.8.8.1. Key country dynamics
- 6.8.8.2. Competitive Scenario
- 6.8.8.3. Regulatory framework
- 6.8.8.4. Reimbursement scenario
- 6.8.8.5. Market estimates and forecasts, 2018 - 2030
- 6.9. Asia Pacific
- 6.9.1. Japan
- 6.9.1.1. Key country dynamics
- 6.9.1.2. Competitive Scenario
- 6.9.1.3. Regulatory framework
- 6.9.1.4. Reimbursement scenario
- 6.9.1.5. Market estimates and forecasts, 2018 - 2030
- 6.9.2. China
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Competitive Scenario
- 6.9.2.3. Regulatory framework
- 6.9.2.4. Reimbursement scenario
- 6.9.2.5. Market estimates and forecasts, 2018 - 2030
- 6.9.3. India
- 6.9.3.1. Key country dynamics
- 6.9.3.2. Competitive Scenario
- 6.9.3.3. Regulatory framework
- 6.9.3.4. Reimbursement scenario
- 6.9.3.5. Market estimates and forecasts, 2018 - 2030
- 6.9.4. Thailand
- 6.9.4.1. Key country dynamics
- 6.9.4.2. Competitive Scenario
- 6.9.4.3. Regulatory framework
- 6.9.4.4. Reimbursement scenario
- 6.9.4.5. Market estimates and forecasts, 2018 - 2030
- 6.9.5. South Korea
- 6.9.5.1. Key country dynamics
- 6.9.5.2. Competitive Scenario
- 6.9.5.3. Regulatory framework
- 6.9.5.4. Reimbursement scenario
- 6.9.5.5. Market estimates and forecasts, 2018 - 2030
- 6.10. Latin America
- 6.10.1. Brazil
- 6.10.1.1. Key country dynamics
- 6.10.1.2. Competitive Scenario
- 6.10.1.3. Regulatory framework
- 6.10.1.4. Reimbursement scenario
- 6.10.1.5. Market estimates and forecasts, 2018 - 2030
- 6.10.2. Mexico
- 6.10.2.1. Key country dynamics
- 6.10.2.2. Competitive Scenario
- 6.10.2.3. Regulatory framework
- 6.10.2.4. Reimbursement scenario
- 6.10.2.5. Market estimates and forecasts, 2018 - 2030
- 6.10.3. Argentina
- 6.10.3.1. Key country dynamics
- 6.10.3.2. Competitive Scenario
- 6.10.3.3. Regulatory framework
- 6.10.3.4. Reimbursement scenario
- 6.10.3.5. Market estimates and forecasts, 2018 - 2030
- 6.11. MEA
- 6.11.1. South Africa
- 6.11.1.1. Key country dynamics
- 6.11.1.2. Competitive Scenario
- 6.11.1.3. Regulatory framework
- 6.11.1.4. Reimbursement scenario
- 6.11.1.5. Market estimates and forecasts, 2018 - 2030
- 6.11.2. Saudi Arabia
- 6.11.2.1. Key country dynamics
- 6.11.2.2. Competitive Scenario
- 6.11.2.3. Regulatory framework
- 6.11.2.4. Reimbursement scenario
- 6.11.2.5. Market estimates and forecasts, 2018 - 2030
- 6.11.3. UAE
- 6.11.3.1. Key country dynamics
- 6.11.3.2. Competitive Scenario
- 6.11.3.3. Regulatory framework
- 6.11.3.4. Reimbursement scenario
- 6.11.3.5. Market estimates and forecasts, 2018 - 2030
- 6.11.4. Kuwait
- 6.11.4.1. Key country dynamics
- 6.11.4.2. Competitive Scenario
- 6.11.4.3. Regulatory framework
- 6.11.4.4. Reimbursement scenario
- 6.11.4.5. Market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2021
- 7.3.4. Koninklijke Philips N.V.
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. GE Healthcare
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Siemens Healthcare
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Canon Medical Systems
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Mindray Medical International
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Esaote
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Hologic, Inc
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Samsung Medison Co.Ltd
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Koning Corporation
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Perkin Elmer Inc.
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Product benchmarking
- 7.3.13.4. Strategic initiatives
- 7.3.14. FUJIFILM VisualSonics Inc.
- 7.3.14.1. Company overview
- 7.3.14.2. Financial performance
- 7.3.14.3. Product benchmarking
- 7.3.14.4. Strategic initiatives
- 7.3.15. Cubresa Inc.
- 7.3.15.1. Company overview
- 7.3.15.2. Financial performance
- 7.3.15.3. Product benchmarking
- 7.3.15.4. Strategic initiatives